About Hikma Pharma
Hikma Pharmaceuticals is a British pharmaceutical company headquartered in London. Founded in 1978, it focuses on developing, manufacturing, marketing and selling a wide range of generic, non-branded, branded and in-licensed medical products in various forms, including liquid, semi-solid, and injectables. Hikma is a global business with 32 manufacturing plants and 7 research and development centres across Europe, the Middle East, the US, and North Africa. The company’s therapeutic areas of interest include cardiovascular, oncology, anti-infectives, respiratory, central nervous system, diabetes, and pain management, where it offers more than 780 products to patients. Hikma Pharmaceuticals stock is listed on the London Stock Exchange and is a constituent of the FTSE 100 index. Start spread betting or trading CFDs on our Hikma share price.
Constituent weightings
Component |
Weighting |
1 Day |
1 Month |
3 Month |
Related instruments
Why trade Hikma Pharma with CMC Markets?
We've invested over £100m into our trading platform, creating pioneering technology that puts powerful software in your hands.
-
One-click trading
Set your default position size and enter with a single 'click'.
-
99.9% fill rate with 0.0029s execution*
Wherever possible we fill your trade and always at the price you see.
-
99.95%+ platform stability**
We consistently achieve core platform uptime, allowing you to focus on your trading.
-
Precise pricing
We crunch 225m prices every day, from up to 14 feeds from tier one liquidity providers.
Related news